Alphaeon

Strathspey Crown Holdings subsidiary and social commerce firm Alphaeon has completed the acquisition of US-based commercial stage medical device firm, Lensar, for an undisclosed amount.

Established in 2004, Lensar is a developer and manufacturer of femtosecond laser systems (FLS) through a wholly owned subsidiary.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

At the signing of the agreement in November, Alphaeon noted the transaction is valued at up to $59m in cash, stock and assumed debt.

The company developed the femtosecond cataract laser to enable automation of critical surgical procedure planning.

The Lensar laser system provides patients with better outcomes following the removal of their crystalline lens.

Alphaeon CEO Robert Grant said: "We are pleased to have closed the acquisition of Lensar.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio."

"The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio, allowing ophthalmologists to offer another alternative to patients."

The acquisition allows Alphaeon to expand its ophthalmology business, offering advanced technology to its network of more than 4,200 board certified ophthalmologists worldwide.

Last December, Alphaeon also acquired Canada-based Clarion Medical Technologies for $55m.

Established in 1989, Clarion supplies medical and aesthetic equipment and consumables for hospitals and private practices in Canada. Formerly known as Coherent-AMT, Clarion has 100 employees, 36 sales representatives and more than 40 product licenses.

Alphaeon is a lifestyle healthcare firm that works with board certified physicians to provide new products and services.

Strathspey Crown is an equity firm specialising in lifestyle healthcare and its investors include board certified physician specialists across key medical specialties, comprising plastic surgery, ophthalmology, dermatology, dentistry and orthopaedics.


Image: Alphaeon Corporation in Irvine, California. Photo: courtesy of Alphaeon.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact